These include alterations in e.g. MSH4, PRDM2, and TP53I3 in the MSI tumor as well as GATA, DOCK5, and IGSF11 in the MSS tumor (Additional file 2: Table S2 + S3). This evidence concerns the gene PRDM2 and Marinesco-Sjogren syndrome.